Literature DB >> 8947822

Could in vitro fertilization with a modified sperm preparation technique be an option to micromanipulations?

C Wittemer1, J Ohl, K Bettahar-Lebugle, L Moreau, P Dellenbach.   

Abstract

PURPOSE: This study evaluated the efficiency of in vitro fertilization with a modified sperm preparation technique for male infertility, to avoid systematic recourse to ICSI.
METHODS: The sperm function stimulants pentoxifylline, 2-deoxyadenosine, and follicular fluid were used during the sperm preparation of IVF trials for two groups of patients: couples with long-standing infertility and previous IVF failures and couples with male-factor infertility scheduled for their first treatment.
RESULTS: Forty-nine attempts were performed in the first group. The overall fertilization rate (percentage of zygotes with two pronuclei 18 hr after sperm insemination) was 30% and the clinical pregnancy rate per transfer was 33%. For the second group, 30 attempts were performed. The fertilization rate was 29.6% and the clinical pregnancy rate was 62.5% per transfer. The total number of recovered motile sperm appears to be a significant parameter: a cutoff value of 0.25 million motile sperm recovered after capacitation treatment has a good prognostic value for choosing between IVF with sperm enhancers and ICSI.
CONCLUSIONS: The described modified IVF could constitute an alternative to the systematic use of ICSI.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8947822     DOI: 10.1007/bf02066427

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  11 in total

1.  High fertilization and implantation rates after intracytoplasmic sperm injection.

Authors:  A C Van Steirteghem; Z Nagy; H Joris; J Liu; C Staessen; J Smitz; A Wisanto; P Devroey
Journal:  Hum Reprod       Date:  1993-07       Impact factor: 6.918

2.  The effect of the motility stimulants, caffeine, pentoxifylline, and 2-deoxyadenosine on hyperactivation of cryopreserved human sperm.

Authors:  M T Mbizvo; R C Johnston; G H Baker
Journal:  Fertil Steril       Date:  1993-05       Impact factor: 7.329

3.  Influence of pentoxifylline in severe male factor infertility.

Authors:  J M Yovich; W R Edirisinghe; J M Cummins; J L Yovich
Journal:  Fertil Steril       Date:  1990-04       Impact factor: 7.329

4.  In vitro fertilization and embryonic development of oocytes fertilized by sperm treated with 2-deoxyadenosine.

Authors:  D A Imoedemhe; A B Sigue; E L Pacpaco; A B Olazo
Journal:  Int J Fertil Menopausal Stud       Date:  1993 Jul-Aug

Review 5.  Pentoxifylline: actions and applications in assisted reproduction.

Authors:  J L Yovich
Journal:  Hum Reprod       Date:  1993-11       Impact factor: 6.918

Review 6.  An argument for the past and continued use of pentoxifylline in assisted reproductive technology.

Authors:  P L Matson; J M Yovich; W R Edirisinghe; S M Junk; J L Yovich
Journal:  Hum Reprod       Date:  1995-10       Impact factor: 6.918

7.  Modification of the sperm penetration assay using human follicular fluid to minimize false negative results.

Authors:  B Yee; L M Cummings
Journal:  Fertil Steril       Date:  1988-07       Impact factor: 7.329

8.  The effect of pentoxifylline on sperm movement characteristics and zona pellucida binding potential of teratozoospermic men.

Authors:  K Kaskar; D R Franken; G van der Horst; T F Kruger
Journal:  Hum Reprod       Date:  1994-03       Impact factor: 6.918

9.  Incubation of spermatozoa from asthenozoospermic semen samples with pentoxifylline and 2-deoxyadenosine: variability in hyperactivation and acrosome reaction rates.

Authors:  H Tournaye; P Wieme; R Janssens; G Verheyen; P Devroey; A Van Steirteghem
Journal:  Hum Reprod       Date:  1994-11       Impact factor: 6.918

10.  In vitro fertilization in couples with previous fertilization failure using sperm incubated with pentoxifylline and 2-deoxyadenosine.

Authors:  H Tournaye; R Janssens; G Verheyen; P Devroey; A Van Steirteghem
Journal:  Fertil Steril       Date:  1994-09       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.